Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2017. Start Trial.
Date Value
November 06, 2026 2.480
November 05, 2026 2.41
November 04, 2026 2.69
November 03, 2026 2.82
November 02, 2026 2.80
October 30, 2026 3.43
October 29, 2026 3.90
October 28, 2026 4.14
October 27, 2026 3.93
October 26, 2026 3.69
October 23, 2026 3.386
October 22, 2026 3.312
October 21, 2026 3.359
October 20, 2026 3.084
October 19, 2026 3.125
October 16, 2026 3.649
October 15, 2026 3.451
October 14, 2026 3.879
October 13, 2026 2.802
October 12, 2026 3.066
October 09, 2026 3.682
October 08, 2026 4.190
October 07, 2026 4.510
October 06, 2026 4.761
October 05, 2026 4.914
Date Value
October 02, 2026 4.959
October 01, 2026 5.061
September 30, 2026 5.249
September 29, 2026 5.161
September 28, 2026 5.437
September 25, 2026 5.408
September 24, 2026 5.40
September 23, 2026 5.515
September 22, 2026 5.448
September 21, 2026 5.439
September 18, 2026 5.84
September 17, 2026 6.399
September 16, 2026 7.68
September 15, 2026 10.64
September 14, 2026 8.96
September 11, 2026 10.40
September 10, 2026 5.281
September 09, 2026 6.498
September 08, 2026 6.646
September 04, 2026 6.784
September 03, 2026 6.387
September 02, 2026 6.279
September 01, 2026 6.246
August 31, 2026 6.494
August 28, 2026 6.945

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
NuCana Plc 0.9377
Mereo BioPharma Group Plc 0.283
BioNTech SE 88.69
Silence Therapeutics Plc 6.355
Autolus Therapeutics Plc 1.28